Shell disease is a problem affecting lobsters in eastern Long Island Sound causing disfiguration of the shell, decreasing the lobsters' value, and whereas mild and medium levels of the disease are not lethal, ultimately, severe cases result in mortality. Levels of the molting hormone, ecdysone, were quantitated, using a radioimmunoassay (RIA), in hemolymph of animals exhibiting shell disease. Our results indicate that levels of ecdysone were increased in the hemolymph of shell-diseased lobsters, with a medium level of expression of the disease to 89 ± 32 ng/mL (n = 76), whereas unaffected, presumably healthy ones had 57 ± 16 ng/mL (n = 210). In 7 of 10 months of the year shell-diseased animals had higher ecdysone levels in their hemolymph than unaffected animals. In addition, ecdysone levels were abnormally high, 165 ± 53 ng/mL (n = 5), in shell-diseased ovigerous lobsters, whereas normal unaffected ovigerous ones had low levels of this hormone, 13 ± 4 ng/mL (n = 7). These results indicate that shell disease may induce lobsters to alter the systemic levels of ecdysone, possibly serving as a defensive measure, allowing the animals to ward off the effects of shell disease through induced molting.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 24 • No. 3